Your browser doesn't support javascript.
loading
Improving breast cancer sensitivity to paclitaxel by increasing aneuploidy.
Rodrigues-Ferreira, Sylvie; Nehlig, Anne; Moindjie, Hadia; Monchecourt, Clarisse; Seiler, Cynthia; Marangoni, Elisabetta; Chateau-Joubert, Sophie; Dujaric, Marie-Eglantine; Servant, Nicolas; Asselain, Bernard; de Cremoux, Patricia; Lacroix-Triki, Magali; Arnedos, Monica; Pierga, Jean-Yves; André, Fabrice; Nahmias, Clara.
Afiliação
  • Rodrigues-Ferreira S; INSERM U981, LabEx LERMIT, Department of Molecular Medicine, Gustave Roussy Research Center, Université Paris Saclay, 94800 Villejuif, France.
  • Nehlig A; INSERM U981, LabEx LERMIT, Department of Molecular Medicine, Gustave Roussy Research Center, Université Paris Saclay, 94800 Villejuif, France.
  • Moindjie H; INSERM U981, LabEx LERMIT, Department of Molecular Medicine, Gustave Roussy Research Center, Université Paris Saclay, 94800 Villejuif, France.
  • Monchecourt C; INSERM U981, LabEx LERMIT, Department of Molecular Medicine, Gustave Roussy Research Center, Université Paris Saclay, 94800 Villejuif, France.
  • Seiler C; INSERM U981, LabEx LERMIT, Department of Molecular Medicine, Gustave Roussy Research Center, Université Paris Saclay, 94800 Villejuif, France.
  • Marangoni E; Laboratory of Preclinical Investigations, Translational Research Department, Institut Curie, Université Paris-Sciences-et-Lettres, 75005 Paris, France.
  • Chateau-Joubert S; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94700 Maisons Alfort, France.
  • Dujaric ME; Institut Curie, Université Paris-Sciences-et-Lettres, Mines ParisTech, Bioinformatics and Computational Systems Biology of Cancer, 75005 Paris, France.
  • Servant N; INSERM U900, Unit of Biometry, Institut Curie, Université Paris-Sciences-et-Lettres, 75005 Paris, France.
  • Asselain B; Institut Curie, Université Paris-Sciences-et-Lettres, Mines ParisTech, Bioinformatics and Computational Systems Biology of Cancer, 75005 Paris, France.
  • de Cremoux P; Assistance Publique Hopitaux de Paris Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 75010 Paris, France.
  • Lacroix-Triki M; Department of Medical Oncology, Gustave Roussy Research Center, 94800 Villejuif, France.
  • Arnedos M; Department of Medical Oncology, Gustave Roussy Research Center, 94800 Villejuif, France.
  • Pierga JY; Medical Oncology Department, Institut Curie, Saint Cloud Hospital, Université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France.
  • André F; INSERM U981, LabEx LERMIT, Department of Molecular Medicine, Gustave Roussy Research Center, Université Paris Saclay, 94800 Villejuif, France.
  • Nahmias C; Department of Medical Oncology, Gustave Roussy Research Center, 94800 Villejuif, France.
Proc Natl Acad Sci U S A ; 116(47): 23691-23697, 2019 11 19.
Article em En | MEDLINE | ID: mdl-31685623
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Proteínas Supressoras de Tumor / Aneuploidia / Proteínas de Neoplasias / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Proteínas Supressoras de Tumor / Aneuploidia / Proteínas de Neoplasias / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França